BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 4, 2006
View Archived Issues
URB-597 demonstrates anxiolytic and antidepressant effects in preclinical models
Read More
NNZ-3006 shows fat reduction capabilities in animal model
Read More
Juvista administration at time of surgery improves scar appearance
Read More
Ranbaxy presents novel linezolid analogues at ICAAC
Read More
R&D highlights from the UBS Global Life Sciences Conference in New York: Human Genome Sciences
Read More
Positive phase II results for Alpharma's abuse-deterrent, extended-release opioid
Read More
MediGene completes acquisition of Avidex
Read More
Inhibiting cathepsin K: effective blockade of bone resorption. Part I: clinical activity
Read More
PhotoCure completes phase IIa acne study of MAL cream
Read More
Studies examine effects of FTY-720 in multiple sclerosis
Read More
Imidacrine improves demyelinating disease in guinea pigs
Read More
Phase I studies determine CDP-323 pharmacokinetics, pharmacodynamics
Read More
Long-term ibandronate findings in postmenopausal osteoporosis presented
Read More
FDA requests additional trial to support approval of ruboxistaurin mesylate
Read More
Amgen to acquire Avidia
Read More
Innovive discontinues development of INNO-105
Read More
Gilead Sciences to acquire Myogen
Read More
Psychotropic compound Lu-AA44608 begins clinical testing
Read More
Avantogen files IND for phase II studies of RP-101 in metastatic pancreatic cancer
Read More
Nonclinical section of Onconase rolling NDA completed
Read More
EpiCept files IND for microtubulin inhibitor EPC-2407
Read More
Xenon and Takeda sign agreement for pain product XEN-401 in Japan and Asia
Read More
FM-VP4 completes phase II study in hypercholesterolemia
Read More
Alista has potential in female sexual arousal disorder
Read More
AS-1411 shows promise in renal and lung cancers
Read More
Novel BACE inhibitors emerge from Bristol-Myers Squibb R&D
Read More
Fast track designation for pralatrexate in T-cell lymphoma
Read More
Abbott begins roll-out of Xience V stent
Read More
Boehringer Ingelheim patent claims novel coagulation factor Xa inhibitors
Read More
Novel analgesic agents imparted in recent Pfizer patents
Read More
Cethromycin: preclinical and clinical update presented at the ICAAC meeting
Read More